Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindu.com -  The Hindu Bureau - VSU signs MoU with Malladi Drugs to make pharma students industry-ready
VSU signs MoU with Malladi Drugs to make pharma students industry-ready
The Hindu –

With the aim of providing students with quality education, technical knowledge and practical skills required in the pharmaceutical industry, Vikrama Simhapuri University (VSU), through its College of Pharmaceutical Sciences, Kavali, has entered…

thehindubusinessline.com - Anupama Ghosh - Profit-booking drags Nifty below 25,200; Pharma holds firm as metals, durables bleed
Profit-booking drags Nifty below 25,200; Pharma holds firm as metals, durables bleed
The HinduBusinessLine –

Updated - November 18, 2026 at 01:27 PM. Benchmark indices fell sharply in mid-session trade on Wednesday, with broad-based profit-booking accelerating after the morning open. The Sensex was down 624.97 points or 0.76 per cent at 81,907.22 as of…

marketbeat.com - Royalty Pharma (NASDAQ:RPRX) Stock Price Target Raised at TD Cowen
Royalty Pharma (NASDAQ:RPRX) Stock Price Target Raised at TD Cowen
MarketBeat –

Royalty Pharma (NASDAQ:RPRX - Get Free Report) had its price target hoisted by stock analysts at TD Cowen from $68.00 to $80.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a 'buy' rating on the…

themeasure.net - Eleanor Semeraro - SAGE Says: The Power of Purpose in Pharma Advertising
SAGE Says: The Power of Purpose in Pharma Advertising
The Measure –

The pharmaceutical category is one of the most prolific TV advertisers, spending billions of dollars annually across linear and streaming CTV. We asked iSpot SAGE to dig up some of the most effective non-OTC pharma ads from the second half of this…

marketbeat.com - BridgeBio Pharma, Inc. $BBIO Shares Newly Bought by Aberdeen Group plc
BridgeBio Pharma, Inc. $BBIO Shares Newly Bought by Aberdeen Group plc
MarketBeat –

Aberdeen Group plc purchased a new stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 301,848 shares of the…

marketbeat.com - Nuvectis Pharma, Inc. (NASDAQ:NVCT) Stock Has Consensus Target Price of $36.25
Nuvectis Pharma, Inc. (NASDAQ:NVCT) Stock Has Consensus Target Price of $36.25
MarketBeat –

Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report) has received an average rating of 'Moderate Buy' from the six brokerages that are covering the company, MarketBeat reports. Two analysts have rated the stock with a sell rating, three have…

marketbeat.com - NewAmsterdam Pharma Sees Unusually Large Options Volume (NASDAQ:NAMS)
NewAmsterdam Pharma Sees Unusually Large Options Volume (NASDAQ:NAMS)
MarketBeat –

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) saw some unusual options trading on Tuesday. Traders acquired 7,505 call options on the company. This is an increase of approximately 962% compared to the typical volume of 707 call…

marketbeat.com - NewAmsterdam Pharma Sees Unusually High Options Volume (NASDAQ:NAMS)
NewAmsterdam Pharma Sees Unusually High Options Volume (NASDAQ:NAMS)
MarketBeat –

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) was the target of some unusual options trading on Tuesday. Stock traders purchased 7,505 call options on the company. This is an increase of 962% compared to the typical volume of 707…

marketbeat.com - Avalyn Pharma (NASDAQ:AVLN) Share Price Crosses Below Fifty Day Moving Average on Analyst Downgrade
Avalyn Pharma (NASDAQ:AVLN) Share Price Crosses Below Fifty Day Moving Average on Analyst Downgrade
MarketBeat –

Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) shares passed below its 50-day moving average during trading on Tuesday after Morgan Stanley lowered their price target on the stock from $57.00 to $53.00. The stock has a 50-day moving average of…

thehindubusinessline.com - KS Badri Narayanan - Stocks to watch, Nov 18: ArMee Info, IIFL Finance, RITES, Supreme Petrochem, Glenmark, Mankind Pharma, Ashok Buildcon, Advait Energy, Apollo Micro, Nykaa
Stocks to watch, Nov 18: ArMee Info, IIFL Finance, RITES, Supreme Petrochem, Glenmark, Mankind Pharma, Ashok Buildcon, Advait Energy, Apollo Micro, Nykaa
The HinduBusinessLine –

RITES has entered into an MoU with National Mission for Clean Ganga [an authority under the Environment (Protection) Act, 1986 (EPA)]. This MoU will establish a long term working mechanism between RITES and NMCG to collaborate on the preparation of…

seekingalpha.com - Albert Anthony - One Liberty Properties: Upgrade After Q3, As Industrial Portfolio Grows Selectively
One Liberty Properties: Upgrade After Q3, As Industrial Portfolio Grows Selectively
Seeking Alpha –

Albert Anthony is the pen name of a business author on Amazon and a contributing analyst to investing platforms like Seeking Alpha since 2023, where he has over + 2,000 followers and has covered hundreds of stocks in multiple sectors including…

afr.com - Joyce Moullakis - Nuix takeover offer caps off a wild six-year rollercoaster ride
Nuix takeover offer caps off a wild six-year rollercoaster ride
Australian Financial Review –

It's almost exactly six years since Nuix debuted on the ASX with much fanfare, and now it looks as though the analytics and intelligence software group will be plucked off the exchange in the coming months. The Macquarie-backed business is just the…

seekingalpha.com - ALLKA Research - Pfizer: The Patent Cliff Fears Are Overblown
Pfizer: The Patent Cliff Fears Are Overblown
Seeking Alpha –

Pfizer Inc., a Big Pharma player offering a 5.96% dividend yield, remains a controversial choice among long-term retail investors. Most concerns reflect PFE's upcoming patent expiration cycle, which is expected to last about 3 years. However, I…

theguardian.com - Barry Glendenning - Football Daily | From Cincinnati to Manchester: Pochettino in a hurry to paint town red
Football Daily | From Cincinnati to Manchester: Pochettino in a hurry to paint town red
The Guardian –

With his team mired in the relegation zone and a massive match at Liverpool this weekend, Mauricio Pochettino has been understandably busy since being appointed head coach of Manchester United. Unfortunately for Old Trafford regulars, the small…

smh.com.au - John Buckley - Rupert approves? News Corp staff get free tickets to preview of new Murdoch movie
Rupert approves? News Corp staff get free tickets to preview of new Murdoch movie
The Sydney Morning Herald –

You have reached your maximum number of saved items. Remove items from your saved list to add more. You've used all of your gift articles. 3 more will become available on the 1st of every month. It's unclear whether Danny Boyle, who directed the…

Receive a Daily briefing on Pharma Industry News

Get Started